MIRAPEX.com: Safety and dosing

Well tolerated at all stages of PD

MIRAPEX is well tolerated in patients with early and advanced disease

No predicted P450 drug interactions^6,23,24

MIRAPEX does not interact with many prescribed medications*

*Urinary excretion is the major route of MIRAPEX elimination, with 90% of dose recovered in urine. Dosage should be adjusted in patients with renal impairment.

Learn more

Flexible titration²⁰

MIRAPEX quickly (2-3 weeks) titrates to an effective dose and offers a flexible dosing schedule

Learn more

Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including MIRAPEX, to treat Parkinson's disease.

Download a MIRAPEX Patient Dosing Guide

Important information about MIRAPEX:

Mirapex® (pramipexole dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease.
Patients have reported falling asleep without perceived warning signs during activities of daily living, including operation of a motor vehicle, which sometimes resulted in accidents. Hallucinations and postural (orthostatic) hypotension may occur.
The most commonly reported adverse events in early and late disease in clinical trials were dizziness, dyskinesia, extrapyramidal syndrome, hallucinations, headache, insomnia, somnolence, and nausea.

Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease.

Please see full Prescribing Information.

This information is intended for US residents only.

Well tolerated at all stages of PD

No predicted P450 drug interactions6,23,24

Flexible titration20

No predicted P450 drug interactions^6,23,24

Flexible titration²⁰